Abstract
Structure-activity studies of 1H-pyrazolo[3,4-b]pyridine 1 have resulted in the discovery of potent CDK1/CDK2 selective inhibitor 21h, BMS-265246 (CDK1/cycB IC(50)=6 nM, CDK2/cycE IC(50)=9 nM). The 2,6-difluorophenyl substitution was critical for potent inhibitory activity. A solid state structure of 21j, a close di-fluoro analogue, bound to CDK2 shows the inhibitor resides coincident with the ATP purine binding site and forms important H-bonds with Leu83 on the protein backbone.
MeSH terms
-
Adenosine Triphosphate / metabolism
-
Binding Sites / drug effects
-
CDC2-CDC28 Kinases / antagonists & inhibitors
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases / antagonists & inhibitors*
-
Cyclin-Dependent Kinases / chemistry
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology*
-
Hydrogen Bonding
-
Indicators and Reagents
-
Leucine / chemistry
-
Models, Molecular
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / pharmacology*
-
Pyridines / chemical synthesis*
-
Pyridines / pharmacology*
-
Structure-Activity Relationship
Substances
-
Enzyme Inhibitors
-
Indicators and Reagents
-
Pyrazoles
-
Pyridines
-
Adenosine Triphosphate
-
CDC2-CDC28 Kinases
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases
-
Leucine